Drug Profile
SOM 2485
Alternative Names: sigma-1 agonist - SOM Biotech; SOM2485Latest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator SOM Biotech
- Class Small molecules
- Mechanism of Action Sigma-1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 31 Aug 2023 Discontinued - Preclinical for Alzheimer's disease in Spain (unspecified route)
- 28 May 2020 No recent reports of development identified for preclinical development in Alzheimer's-disease in Spain
- 12 Apr 2016 SOM 2485 is available for licensing as of 12 Apr 2016. http://www.sombiotech.com